Melbourne man jailed for insider trading of ASX shares

Former executive of a listed company sentenced after selling his stocks while aware of information that the public was not privy to.

asx share penalty represented by lots of fingers pointing at disgraced businessman Crown royal commission WA

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A Melbourne man has been sentenced to 14 months' imprisonment for insider trading of ASX shares.

The County Court of Victoria on Monday handed down the sentence to former Sigma Healthcare Ltd (ASX: SIG) general manager Michael Story of Elwood, Victoria.

Story was also ordered to pay a fine of $30,000 and a penalty of $70,179.37, which was the level of benefit he illegally derived from insider trading.

The court found the executive sold his Sigma shares while he had information about the business that the public did not know about.

Sold his shares before they fell 40%

The insider information related to Sigma's supplier relationship to giant pharmacy retailer Chemist Warehouse.

On 2 July 2018, Sigma announced to the ASX that its supply contract would cease on 30 June 2019. This significant loss of business led to the share price plunging 40% that day.

An Australian Securities and Investments Commission investigation found Story was "heavily involved" in the contract negotiations, and privately knew the deal wouldn't be renewed.

He was also aware that the failure to renew the Chemist Warehouse relationship would have a massive impact on the Sigma stock price.

Despite knowing this, he sold 250,000 Sigma shares for $202,629.

ASIC deputy chair Sarah Court said Story was "a true insider" who had "sensitive company information" that would impact the share price. 

"He sold his shares with inside information, giving him an unfair advantage," she said.

"This criminal conduct threatens the integrity of Australia's financial markets. ASIC will continue to pursue cases of using inside information to illegally trade on our markets."

No other reason other than personal benefit

Judge Simon Moglia condemned Story's dishonesty and found there was no explanation for his actions other than to avoid personal loss.

The former executive would have been sentenced to two years' imprisonment if he had not pleaded guilty and instead contested the accusations. 

Story was released upon a recognizance of $5,000 and a three-year good behaviour period.

At the time of Story's offences, the maximum penalty for insider trading was 10 years' jail. It is now 15 years.

The Commonwealth director of public prosecutions prosecuted the case against the former executive after an ASIC referral.

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today

These shares are ending the week on a high. But why?

Read more »

Time to sell ASX 200 shares written on a clock.
Share Market News

Sell alert! Why analysts are calling time on these 2 ASX 300 stocks

Two leading investment experts recommend selling these ASX 300 shares today. But why?

Read more »